HHS

Pharma Update January 2022

The pharmaceutical market plays a key role in how people get medications and what people pay for medication. At the intersection of healthcare, pharma, and technology, here are current news and announcements.




HHS Priorities for 2022

Looking at 2022 the HHS reported its regulatory and deregulatory rule proposals for inclusion in the Administrations unified agenda released in December. We take a look at the ONC, CMS, and HRSA agencies under HHS.





HHS Is Releasing $9 Billion in Provider Relief Fund Payments

The U.S. Department of Health and Human Services, through the Health Resources and Services Administration, announced the distribution of approximately $9 billion in Provider Relief Fund Phase 4 payments to health care providers who have experienced revenue losses and expenses related to the COVID-19 pandemic.